Peptides provide an effective therapy for hypoparathyroidism, with PTH replacement offering a superior physiologic treatment compared to conventional therapy with active vitamin D and calcium, which address hypocalcemia but fail to restore normal PTH function. The gene discussed is PTH; the disease is Hypocalcemia.